Table S3 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
William Proctor Harris
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
138Publications signalées
7902Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Hepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchFibroblast Growth Factor ResearchColorectal Cancer Treatments and Studies
Les publications récentes
Table S2 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Table S4 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Figure 4 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Table 3 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Table S1 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Table 1 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Figure 1 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Figure 2 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Table 2 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Data from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
Figure 3 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer
Anne B. Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.